ROMERIO, ALESSIO
ROMERIO, ALESSIO
DIPARTIMENTO DI BIOTECNOLOGIE E BIOSCIENZE
Increasing the Chemical Variety of Small-Molecule-Based TLR4 Modulators: An Overview
2020 Romerio, A; Peri, F
NEW SYNTHETIC AGONISTS OF TLR4 RECEPTOR
2021 Peri, F; Romerio, A; D'Amato, S
Synthetic Glycolipids as Molecular Vaccine Adjuvants: Mechanism of Action in Human Cells and in Vivo Activity
2021 Facchini, F; Minotti, A; Luraghi, A; Romerio, A; Gotri, N; Matamoros-Recio, A; Iannucci, A; Palmer, C; Wang, G; Ingram, R; Martin-Santamaria, S; Pirianov, G; De Andrea, M; Valvano, M; Peri, F
Highly Selective SERCA2a Activators: Preclinical Development of a Congeneric Group of First-in-Class Drug Leads against Heart Failure
2022 Luraghi, A; Ferrandi, M; Barassi, P; Arici, M; Hsu, S; Torre, E; Ronchi, C; Romerio, A; Chang, G; Ferrari, P; Bianchi, G; Zaza, A; Rocchetti, M; Peri, F
Potentiation of fluoroquinolone and macrolide activities by efflux pump inhibitory effect on Staphylococcus aureus and Streptococcus pyogenes of new benzyl piperazinyl lysine derivatives
2023 Musumeci, R; Martinelli, M; Giubbi, C; Perdoni, F; Romerio, A; Vertemara, J; De Gioia, L; Peri, F; Cocuzza, C
Synthesis and Biological Characterization of TLR4 Agonists as Innovative Vaccine Adjuvants
2023 Romerio, A
Overcoming Challenges in Chemical Glycosylation to Achieve Innovative Vaccine Adjuvants Possessing Enhanced TLR4 Activity
2023 Romerio, A; Franco, A; Shadrick, M; Shaik, M; Artusa, V; Italia, A; Lami, F; Demchenko, A; Peri, F
New Glucosamine-Based TLR4 Agonists: Design, Synthesis, Mechanism of Action, and In Vivo Activity as Vaccine Adjuvants
2023 Romerio, A; Gotri, N; Franco, A; Artusa, V; Shaik, M; Pasco, S; Atxabal, U; Matamoros-Recio, A; Minguez-Toral, M; Zalamea, J; Franconetti, A; Abrescia, N; Jimenez-Barbero, J; Anguita, J; Martin-Santamaria, S; Peri, F
Cleaner synthesis of preclinically validated vaccine adjuvants
2023 Romerio, A; Peri, F